Effect of change in systolic blood pressure between clinic visits on estimated 10-year cardiovascular disease risk

详细信息    查看全文

• 作者：Siqin Ye ; MD ; MS^a ; ^{sy2357@cumc.columbia.edu" class="auth_mail} ; Y. Claire Wang ; MD ; ScD^b ; Daichi Shimbo ; MD^a ; Jonathan D. Newman ; MD ; MPH^a ; Emily B. Levitan ; ScD^c ; Paul Muntner ; PhD^c
• 关键词：Systolic blood pressure ; risk assessment ; statins ; adults
• 刊名：Journal of the American Society of Hypertension
• 出版年：March, 2014
• 年：2014
• 卷：8
• 期：3
• 页码：159-165
• 全文大小：279 K

文摘

Systolic blood pressure (SBP) often varies between clinic visits within individuals, which can affect estimation of cardiovascular disease (CVD) risk. We analyzed data from participants with two clinic visits separated by a median of 17聽days in the Third National Health and Nutrition Examination Survey (n聽=聽808). Ten-year CVD risk was calculated with SBP obtained at each visit using the Pooled Cohort Equations. The mean age of participants was 46.1聽years, and 47.3% were male. The median SBP difference between the two visits was 鈭?聽mm Hg (1st to 99th percentiles: 鈭?3 to 32聽mm Hg). The median estimated 10-year CVD risk was 2.5% and 2.4% at the first and second visit, respectively (1st to 99th percentiles 鈭?.2% to +7.1%). Meaningful risk reclassification (ie, across the guideline recommended 7.5% threshold for statin initiation) occurred in 12 (11.3%) of 106 participants whose estimated CVD risk was between 5% and 10%, but only in two (0.3%) of 702 participants who had a 10-year estimated CVD risk of <5% or >10%. SBP variability can affect CVD risk estimation, and can influence statin eligibility for individuals with an estimated 10-year CVD risk between 5% and 10%.